Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Leukemia 37Burkitt Lymphoma 13Lymphoma 9Leukemia, Biphenotypic, Acute 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 6Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 4Anemia, Refractory, with Excess of Blasts 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Leukemia, Monocytic, Acute 3Down Syndrome 3Recurrence 2Neutropenia 2Neoplasms 2Neoplasm, Residual 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Dendritic Cell Sarcoma, Interdigitating 2Brain Neoplasms 2Anemia, Refractory 2Thrombocytopenia 1Optic Nerve Glioma 1Lymphoma, T-Cell 1

Interventions

Cytarabine 75Etoposide 31Daunorubicin 27Filgrastim 24Mitoxantrone 23Idarubicin 23Busulfan 22Peripheral Blood Stem Cell Transplantation 20Cyclophosphamide 20fludarabine phosphate 19Gemtuzumab 14tipifarnib 11Antilymphocyte Serum 11Radiotherapy 10Methotrexate 10Cyclosporine 10Clofarabine 10sargramostim 9Gene Expression Profiling 9Flow Cytometry 9Azacitidine 9alvocidib 6aldesleukin 6Whole-Body Irradiation 6Vorinostat 6Topotecan 6Tacrolimus 6Bortezomib 6valspodar 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Erythroblastic, Acute × Thioguanine × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00005823 2013-12-18

Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡